Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias.

Trial Profile

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Dec 2014

At a glance

  • Drugs Clofarabine (Primary) ; Etoposide; Mitoxantrone
  • Indications Leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
    • 17 Jan 2014 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as per Clinicaltrials.gov
    • 17 Jan 2014 Status changed from suspended to active, no longer recruiting as per Clinicaltrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top